Cargando…

Epigenome-wide association study of DNA methylation in panic disorder

BACKGROUND: Panic disorder (PD) is considered to be a multifactorial disorder emerging from interactions among multiple genetic and environmental factors. To date, although genetic studies reported several susceptibility genes with PD, few of them were replicated and the pathogenesis of PD remains t...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimada-Sugimoto, Mihoko, Otowa, Takeshi, Miyagawa, Taku, Umekage, Tadashi, Kawamura, Yoshiya, Bundo, Miki, Iwamoto, Kazuya, Tochigi, Mamoru, Kasai, Kiyoto, Kaiya, Hisanobu, Tanii, Hisashi, Okazaki, Yuji, Tokunaga, Katsushi, Sasaki, Tsukasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5270210/
https://www.ncbi.nlm.nih.gov/pubmed/28149334
http://dx.doi.org/10.1186/s13148-016-0307-1
_version_ 1782501143999414272
author Shimada-Sugimoto, Mihoko
Otowa, Takeshi
Miyagawa, Taku
Umekage, Tadashi
Kawamura, Yoshiya
Bundo, Miki
Iwamoto, Kazuya
Tochigi, Mamoru
Kasai, Kiyoto
Kaiya, Hisanobu
Tanii, Hisashi
Okazaki, Yuji
Tokunaga, Katsushi
Sasaki, Tsukasa
author_facet Shimada-Sugimoto, Mihoko
Otowa, Takeshi
Miyagawa, Taku
Umekage, Tadashi
Kawamura, Yoshiya
Bundo, Miki
Iwamoto, Kazuya
Tochigi, Mamoru
Kasai, Kiyoto
Kaiya, Hisanobu
Tanii, Hisashi
Okazaki, Yuji
Tokunaga, Katsushi
Sasaki, Tsukasa
author_sort Shimada-Sugimoto, Mihoko
collection PubMed
description BACKGROUND: Panic disorder (PD) is considered to be a multifactorial disorder emerging from interactions among multiple genetic and environmental factors. To date, although genetic studies reported several susceptibility genes with PD, few of them were replicated and the pathogenesis of PD remains to be clarified. Epigenetics is considered to play an important role in etiology of complex traits and diseases, and DNA methylation is one of the major forms of epigenetic modifications. In this study, we performed an epigenome-wide association study of PD using DNA methylation arrays so as to investigate the possibility that different levels of DNA methylation might be associated with PD. METHODS: The DNA methylation levels of CpG sites across the genome were examined with genomic DNA samples (PD, N = 48, control, N = 48) extracted from peripheral blood. Methylation arrays were used for the analysis. β values, which represent the levels of DNA methylation, were normalized via an appropriate pipeline. Then, β values were converted to M values via the logit transformation for epigenome-wide association study. The relationship between each DNA methylation site and PD was assessed by linear regression analysis with adjustments for the effects of leukocyte subsets. RESULTS: Forty CpG sites showed significant association with PD at 5% FDR correction, though the differences of the DNA methylation levels were relatively small. Most of the significant CpG sites (37/40 CpG sites) were located in or around CpG islands. Many of the significant CpG sites (27/40 CpG sites) were located upstream of genes, and all such CpG sites with the exception of two were hypomethylated in PD subjects. A pathway analysis on the genes annotated to the significant CpG sites identified several pathways, including “positive regulation of lymphocyte activation.” CONCLUSIONS: Although future studies with larger number of samples are necessary to confirm the small DNA methylation abnormalities associated with PD, there is a possibility that several CpG sites might be associated, together as a group, with PD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-016-0307-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5270210
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52702102017-02-01 Epigenome-wide association study of DNA methylation in panic disorder Shimada-Sugimoto, Mihoko Otowa, Takeshi Miyagawa, Taku Umekage, Tadashi Kawamura, Yoshiya Bundo, Miki Iwamoto, Kazuya Tochigi, Mamoru Kasai, Kiyoto Kaiya, Hisanobu Tanii, Hisashi Okazaki, Yuji Tokunaga, Katsushi Sasaki, Tsukasa Clin Epigenetics Research BACKGROUND: Panic disorder (PD) is considered to be a multifactorial disorder emerging from interactions among multiple genetic and environmental factors. To date, although genetic studies reported several susceptibility genes with PD, few of them were replicated and the pathogenesis of PD remains to be clarified. Epigenetics is considered to play an important role in etiology of complex traits and diseases, and DNA methylation is one of the major forms of epigenetic modifications. In this study, we performed an epigenome-wide association study of PD using DNA methylation arrays so as to investigate the possibility that different levels of DNA methylation might be associated with PD. METHODS: The DNA methylation levels of CpG sites across the genome were examined with genomic DNA samples (PD, N = 48, control, N = 48) extracted from peripheral blood. Methylation arrays were used for the analysis. β values, which represent the levels of DNA methylation, were normalized via an appropriate pipeline. Then, β values were converted to M values via the logit transformation for epigenome-wide association study. The relationship between each DNA methylation site and PD was assessed by linear regression analysis with adjustments for the effects of leukocyte subsets. RESULTS: Forty CpG sites showed significant association with PD at 5% FDR correction, though the differences of the DNA methylation levels were relatively small. Most of the significant CpG sites (37/40 CpG sites) were located in or around CpG islands. Many of the significant CpG sites (27/40 CpG sites) were located upstream of genes, and all such CpG sites with the exception of two were hypomethylated in PD subjects. A pathway analysis on the genes annotated to the significant CpG sites identified several pathways, including “positive regulation of lymphocyte activation.” CONCLUSIONS: Although future studies with larger number of samples are necessary to confirm the small DNA methylation abnormalities associated with PD, there is a possibility that several CpG sites might be associated, together as a group, with PD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-016-0307-1) contains supplementary material, which is available to authorized users. BioMed Central 2017-01-21 /pmc/articles/PMC5270210/ /pubmed/28149334 http://dx.doi.org/10.1186/s13148-016-0307-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Shimada-Sugimoto, Mihoko
Otowa, Takeshi
Miyagawa, Taku
Umekage, Tadashi
Kawamura, Yoshiya
Bundo, Miki
Iwamoto, Kazuya
Tochigi, Mamoru
Kasai, Kiyoto
Kaiya, Hisanobu
Tanii, Hisashi
Okazaki, Yuji
Tokunaga, Katsushi
Sasaki, Tsukasa
Epigenome-wide association study of DNA methylation in panic disorder
title Epigenome-wide association study of DNA methylation in panic disorder
title_full Epigenome-wide association study of DNA methylation in panic disorder
title_fullStr Epigenome-wide association study of DNA methylation in panic disorder
title_full_unstemmed Epigenome-wide association study of DNA methylation in panic disorder
title_short Epigenome-wide association study of DNA methylation in panic disorder
title_sort epigenome-wide association study of dna methylation in panic disorder
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5270210/
https://www.ncbi.nlm.nih.gov/pubmed/28149334
http://dx.doi.org/10.1186/s13148-016-0307-1
work_keys_str_mv AT shimadasugimotomihoko epigenomewideassociationstudyofdnamethylationinpanicdisorder
AT otowatakeshi epigenomewideassociationstudyofdnamethylationinpanicdisorder
AT miyagawataku epigenomewideassociationstudyofdnamethylationinpanicdisorder
AT umekagetadashi epigenomewideassociationstudyofdnamethylationinpanicdisorder
AT kawamurayoshiya epigenomewideassociationstudyofdnamethylationinpanicdisorder
AT bundomiki epigenomewideassociationstudyofdnamethylationinpanicdisorder
AT iwamotokazuya epigenomewideassociationstudyofdnamethylationinpanicdisorder
AT tochigimamoru epigenomewideassociationstudyofdnamethylationinpanicdisorder
AT kasaikiyoto epigenomewideassociationstudyofdnamethylationinpanicdisorder
AT kaiyahisanobu epigenomewideassociationstudyofdnamethylationinpanicdisorder
AT taniihisashi epigenomewideassociationstudyofdnamethylationinpanicdisorder
AT okazakiyuji epigenomewideassociationstudyofdnamethylationinpanicdisorder
AT tokunagakatsushi epigenomewideassociationstudyofdnamethylationinpanicdisorder
AT sasakitsukasa epigenomewideassociationstudyofdnamethylationinpanicdisorder